Table 3

Characteristics of 48 patients on mouth/nasal intermittent positive pressure ventilation (M/NIPPV)

Diagnosis Poliomyelitis Duchenne's muscular dystrophy Other myopathies Motor neurone disease Peripheral neuropathy Multiple sclerosis Kyphoscoliosis S/P lobectomy/ thoracoplasty for TB
No. of patients (M/F)20 (6/14)15 (15/0)2 (1/1)2 (0/2)1 (1/0)2 (1/1)5 (1/4)1 (0/1)
Age when treatment started48.1 (12.6)20.3 (5.0)22 (15.6)43.5 (19.1)4146.5 (3.5)44.8 (9.0)48
Height (cm)166.8 (11.7)172.7 (11.6)165.1 (10.8)152.4 (3.6)182.9160 (0)158.0 (16.0)165.1
Weight (kg)60.6 (14.9)48.0 (15.1)32.5 (8.7)55.7 (14.5)50.595.9 (39.2)40.3 (10.7)63.2
FVC (ml; % predicted)
 a1134 (417);
34 (12)%
600 (219);
14 (5)%
775 (106);
18 (7)%
613 (159);
25 (12)%
1100; 22%1150 (71);
38 (1)%
690 (143.2);
20 (3)%
1200; 41%
 b1219 (417);
37 (14)%
533 (379);
11 (7)%
600 (141);
13 (3)%
850 (212);
34 (17)%
800; 16%1480 (962);
47 (30)%
690 (167.3);
20 (5)%
1100; 33%
Pco 2 (mm Hg)
 a51.7 (15.2)49.7 (7.5)48.0 (5.7)54.0 (8.5)3857.5 (40.3)49.2 (7.2)50
 b45.1 (10.4)3-151 46.7 (8.5)47.0 (9.9)30.5 (3.5)4054.0 (14.1)52.2 (12.4)36
Time on non-invasive ventilation (months)38 (32)22 (22)41 (24)58 (57)517 (10)30 (21)32
Gain or decline in FVC
 ml/year90 (225)−60 (244)−66 (49)104 (112)−720501 (921)−18 (117)−38
 % predicted/year3.6 (8.2)−2.3 (5.9)−1.3 (0.5)4.7 (5.6)−14.414.5 (29.0)−0.36 (3.1)−3.0
No. of patients eventually needing tracheostomy110100000
No. of deaths01010000
  • Values are mean (SD) unless otherwise stated.

  • a = before ventilation; b = near end of period on ventilation; FVC = forced vital capacity; TB = tuberculosis; Pco 2= carbon dioxide tension.

  • 3-151 Significantly different from pre-ventilation Pco 2, p<0.01 (pairedt test).